Your Life. Uninterrupted.
Latest SFC Fluidics News
SFC Fluidics Unveils New Brand Identity and Digital Experience, Signaling a New Era in Precision Drug Delivery | March 13, 2026
SFC Fluidics, a leader in the development of innovative microfluidic drug delivery solutions, is proud to announce the launch of its newly redesigned website and a comprehensive brand refresh. Read More →
SFC Fluidics Collaborating with Duracell to Power Innovative Diabetes Devices | March 18, 2024
The goal of this collaboration is to integrate long-lasting, efficient power solutions into cutting-edge wearable drug delivery systems targeting the treatment of diabetes. Read More →
SFC Fluidics Inc. Receives $2 Million SBIR Grant to Develop Groundbreaking Dual Hormone System for Diabetes Care | July 20, 2023
SFC Fluidics has been awarded a $2 million Small Business Innovation Research (SBIR) Phase II grant to support advanced development of SFC’s wearable Gemini™ Dual Hormone Artificial Pancreas Pod (Gemini-DHAP).
Read More →
Diabeloop SA. and SFC Fluidics Inc. Announce Development Agreement for the United States | Jan 7, 2021
SFC Fluidics Inc., developer of an Alternate Controller Enabled (ACE) insulin delivery pod and Diabeloop, pioneer in therapeutic artificial intelligence, are partnering to integrate the SFC ACE insulin pod into Diabeloop’s Automated Insulin Delivery (AID) solution. Read More →
SFC Fluidics, Inc. Receives FDA Breakthrough Device Designation | Dec 1, 2020
FDA’s BDD program targets novel devices with the potential to provide patients with a more effective treatment for life-threatening or irreversibly debilitating diseases. SFC’s insulin pod promises to substantially improve the lives of patients with diabetes. Read More →